Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Fiona S. L. Brinkman is active.

Publication


Featured researches published by Fiona S. L. Brinkman.


Nature | 2000

Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.

Stover Ck; X. Q. Pham; A. L. Erwin; S. D. Mizoguchi; P. Warrener; M. J. Hickey; Fiona S. L. Brinkman; W. O. Hufnagle; D. J. Kowalik; M. Lagrou; R. L. Garber; L. Goltry; E. Tolentino; S. Westbrock-Wadman; Ye Yuan; L. L. Brody; S. N. Coulter; K. R. Folger; Arnold Kas; K. Larbig; Regina Lim; Kelly D. Smith; David H. Spencer; Gane Ka-Shu Wong; Zhigang Wu; Ian T. Paulsen; Jonathan Reizer; Milton H. Saier; Robert E. W. Hancock; Stephen Lory

Pseudomonas aeruginosa is a ubiquitous environmental bacterium that is one of the top three causes of opportunistic human infections. A major factor in its prominence as a pathogen is its intrinsic resistance to antibiotics and disinfectants. Here we report the complete sequence of P. aeruginosa strain PAO1. At 6.3 million base pairs, this is the largest bacterial genome sequenced, and the sequence provides insights into the basis of the versatility and intrinsic drug resistance of P. aeruginosa. Consistent with its larger genome size and environmental adaptability, P. aeruginosa contains the highest proportion of regulatory genes observed for a bacterial genome and a large number of genes involved in the catabolism, transport and efflux of organic compounds as well as four potential chemotaxis systems. We propose that the size and complexity of the P. aeruginosa genome reflect an evolutionary adaptation permitting it to thrive in diverse environments and resist the effects of a variety of antimicrobial substances.


Bioinformatics | 2010

PSORTb 3.0

Nancy Y. Yu; James R. Wagner; Matthew R. Laird; Gabor Melli; Sébastien Rey; Ray mond Lo; Phuong Dao; S. Cenk Sahinalp; Martin Ester; Leonard J. Foster; Fiona S. L. Brinkman

Motivation: PSORTb has remained the most precise bacterial protein subcellular localization (SCL) predictor since it was first made available in 2003. However, the recall needs to be improved and no accurate SCL predictors yet make predictions for archaea, nor differentiate important localization subcategories, such as proteins targeted to a host cell or bacterial hyperstructures/organelles. Such improvements should preferably be encompassed in a freely available web-based predictor that can also be used as a standalone program. Results: We developed PSORTb version 3.0 with improved recall, higher proteome-scale prediction coverage, and new refined localization subcategories. It is the first SCL predictor specifically geared for all prokaryotes, including archaea and bacteria with atypical membrane/cell wall topologies. It features an improved standalone program, with a new batch results delivery system complementing its web interface. We evaluated the most accurate SCL predictors using 5-fold cross validation plus we performed an independent proteomics analysis, showing that PSORTb 3.0 is the most accurate but can benefit from being complemented by Proteome Analyst predictions. Availability: http://www.psort.org/psortb (download open source software or use the web interface). Contact: [email protected] Supplementary Information: Supplementary data are availableat Bioinformatics online.


Bioinformatics | 2005

PSORTb v.2.0: Expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis

Jennifer L. Gardy; Matthew R. Laird; Fei Chen; Sébastien Rey; C. J. Walsh; Martin Ester; Fiona S. L. Brinkman

MOTIVATION PSORTb v.1.1 is the most precise bacterial localization prediction tool available. However, the programs predictive coverage and recall are low and the method is only applicable to Gram-negative bacteria. The goals of the present work are as follows: increase PSORTbs coverage while maintaining the existing precision level, expand it to include Gram-positive bacteria and then carry out a comparative analysis of localization. RESULTS An expanded database of proteins of known localization and new modules using frequent subsequence-based support vector machines was introduced into PSORTb v.2.0. The program attains a precision of 96% for Gram-positive and Gram-negative bacteria and predictive coverage comparable to other tools for whole proteome analysis. We show that the proportion of proteins at each localization is remarkably consistent across species, even in species with varying proteome size. AVAILABILITY Web-based version: http://www.psort.org/psortb. Standalone version: Available through the website under GNU General Public License. CONTACT [email protected], [email protected] SUPPLEMENTARY INFORMATION http://www.psort.org/psortb/supplementaryinfo.html.


Nucleic Acids Research | 2011

Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes

Geoffrey L. Winsor; David Lam; Leanne Fleming; Raymond Lo; Matthew D. Whiteside; Nancy Y. Yu; Robert E. W. Hancock; Fiona S. L. Brinkman

Pseudomonas is a metabolically-diverse genus of bacteria known for its flexibility and leading free living to pathogenic lifestyles in a wide range of hosts. The Pseudomonas Genome Database (http://www.pseudomonas.com) integrates completely-sequenced Pseudomonas genome sequences and their annotations with genome-scale, high-precision computational predictions and manually curated annotation updates. The latest release implements an ability to view sequence polymorphisms in P. aeruginosa PAO1 versus other reference strains, incomplete genomes and single gene sequences. This aids analysis of phenotypic variation between closely related isolates and strains, as well as wider population genomics and evolutionary studies. The wide range of tools for comparing Pseudomonas annotations and sequences now includes a strain-specific access point for viewing high precision computational predictions including updated, more accurate, protein subcellular localization and genomic island predictions. Views link to genome-scale experimental data as well as comparative genomics analyses that incorporate robust genera-geared methods for predicting and clustering orthologs. These analyses can be exploited for identifying putative essential and core Pseudomonas genes or identifying large-scale evolutionary events. The Pseudomonas Genome Database aims to provide a continually updated, high quality source of genome annotations, specifically tailored for Pseudomonas researchers, but using an approach that may be implemented for other genera-level research communities.


Proceedings of the National Academy of Sciences of the United States of America | 2006

The complete genome of Rhodococcus sp. RHA1 provides insights into a catabolic powerhouse

Michael P. McLeod; René L. Warren; William W. L. Hsiao; Naoto Araki; Matthew Myhre; Clinton Fernandes; Daisuke Miyazawa; Wendy Wong; Anita L. Lillquist; Dennis Wang; Manisha Dosanjh; Hirofumi Hara; Anca Petrescu; Ryan D. Morin; George P. Yang; Jeff M. Stott; Jacqueline E. Schein; Heesun Shin; Duane E. Smailus; Asim Siddiqui; Marco A. Marra; Steven J.M. Jones; Robert A. Holt; Fiona S. L. Brinkman; Keisuke Miyauchi; Masao Fukuda; Julian Davies; William W. Mohn; Lindsay D. Eltis

Rhodococcus sp. RHA1 (RHA1) is a potent polychlorinated biphenyl-degrading soil actinomycete that catabolizes a wide range of compounds and represents a genus of considerable industrial interest. RHA1 has one of the largest bacterial genomes sequenced to date, comprising 9,702,737 bp (67% G+C) arranged in a linear chromosome and three linear plasmids. A targeted insertion methodology was developed to determine the telomeric sequences. RHA1s 9,145 predicted protein-encoding genes are exceptionally rich in oxygenases (203) and ligases (192). Many of the oxygenases occur in the numerous pathways predicted to degrade aromatic compounds (30) or steroids (4). RHA1 also contains 24 nonribosomal peptide synthase genes, six of which exceed 25 kbp, and seven polyketide synthase genes, providing evidence that rhodococci harbor an extensive secondary metabolism. Among sequenced genomes, RHA1 is most similar to those of nocardial and mycobacterial strains. The genome contains few recent gene duplications. Moreover, three different analyses indicate that RHA1 has acquired fewer genes by recent horizontal transfer than most bacteria characterized to date and far fewer than Burkholderia xenovorans LB400, whose genome size and catabolic versatility rival those of RHA1. RHA1 and LB400 thus appear to demonstrate that ecologically similar bacteria can evolve large genomes by different means. Overall, RHA1 appears to have evolved to simultaneously catabolize a diverse range of plant-derived compounds in an O2-rich environment. In addition to establishing RHA1 as an important model for studying actinomycete physiology, this study provides critical insights that facilitate the exploitation of these industrially important microorganisms.


Nucleic Acids Research | 2017

CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database

Baofeng Jia; Amogelang R. Raphenya; Brian Alcock; Nicholas Waglechner; Peiyao Guo; Kara K. Tsang; Briony A. Lago; Biren M. Dave; Sheldon K. Pereira; Arjun N. Sharma; Sachin Doshi; Mélanie Courtot; Raymond Lo; Laura E. Williams; Jonathan G. Frye; Tariq Elsayegh; Daim Sardar; Erin L. Westman; Andrew C. Pawlowski; Timothy A. Johnson; Fiona S. L. Brinkman; Gerard D. Wright; Andrew G. McArthur

The Comprehensive Antibiotic Resistance Database (CARD; http://arpcard.mcmaster.ca) is a manually curated resource containing high quality reference data on the molecular basis of antimicrobial resistance (AMR), with an emphasis on the genes, proteins and mutations involved in AMR. CARD is ontologically structured, model centric, and spans the breadth of AMR drug classes and resistance mechanisms, including intrinsic, mutation-driven and acquired resistance. It is built upon the Antibiotic Resistance Ontology (ARO), a custom built, interconnected and hierarchical controlled vocabulary allowing advanced data sharing and organization. Its design allows the development of novel genome analysis tools, such as the Resistance Gene Identifier (RGI) for resistome prediction from raw genome sequence. Recent improvements include extensive curation of additional reference sequences and mutations, development of a unique Model Ontology and accompanying AMR detection models to power sequence analysis, new visualization tools, and expansion of the RGI for detection of emergent AMR threats. CARD curation is updated monthly based on an interplay of manual literature curation, computational text mining, and genome analysis.


Journal of Immunology | 2006

Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-37

Neeloffer Mookherjee; Kelly L. Brown; Dawn M. E. Bowdish; Silvana Doria; Reza Falsafi; Karsten Hokamp; Fiona M. Roche; Ruixia Mu; Gregory H. Doho; Jelena Pistolic; Jon-Paul Steven Powers; Jenny Bryan; Fiona S. L. Brinkman; Robert E. W. Hancock

The sole human cathelicidin peptide, LL-37, has been demonstrated to protect animals against endotoxemia/sepsis. Low, physiological concentrations of LL-37 (≤1 μg/ml) were able to modulate inflammatory responses by inhibiting the release of the proinflammatory cytokine TNF-α in LPS-stimulated human monocytic cells. Microarray studies established a temporal transcriptional profile and identified differentially expressed genes in LPS-stimulated monocytes in the presence or absence of LL-37. LL-37 significantly inhibited the expression of specific proinflammatory genes up-regulated by NF-κB in the presence of LPS, including NFκB1 (p105/p50) and TNF-α-induced protein 2 (TNFAIP2). In contrast, LL-37 did not significantly inhibit LPS-induced genes that antagonize inflammation, such as TNF-α-induced protein 3 (TNFAIP3) and the NF-κB inhibitor, NFκBIA, or certain chemokine genes that are classically considered proinflammatory. Nuclear translocation, in LPS-treated cells, of the NF-κB subunits p50 and p65 was reduced ≥50% in the presence of LL-37, demonstrating that the peptide altered gene expression in part by acting directly on the TLR-to-NF-κB pathway. LL-37 almost completely prevented the release of TNF-α and other cytokines by human PBMC following stimulation with LPS and other TLR2/4 and TLR9 agonists, but not with cytokines TNF-α or IL-1β. Biochemical and inhibitor studies were consistent with a model whereby LL-37 modulated the inflammatory response to LPS/endotoxin and other agonists of TLR by a complex mechanism involving multiple points of intervention. We propose that the natural human host defense peptide LL-37 plays roles in the delicate balancing of inflammatory responses in homeostasis as well as in combating sepsis induced by certain TLR agonists.


Bioinformatics | 2009

IslandViewer: an integrated interface for computational identification and visualization of genomic islands

Morgan G. I. Langille; Fiona S. L. Brinkman

Summary: Genomic islands (clusters of genes of probable horizontal origin; GIs) play a critical role in medically important adaptations of bacteria. Recently, several computational methods have been developed to predict GIs that utilize either sequence composition bias or comparative genomics approaches. IslandViewer is a web accessible application that provides the first user-friendly interface for obtaining precomputed GI predictions, or predictions from user-inputted sequence, using the most accurate methods for genomic island prediction: IslandPick, IslandPath-DIMOB and SIGI-HMM. The graphical interface allows easy viewing and downloading of island data in multiple formats, at both the chromosome and gene level, for method-specific, or overlapping, GI predictions. Availability: The IslandViewer web service is available at http://www.pathogenomics.sfu.ca/islandviewer and the source code is freely available under the GNU GPL license. Contact: [email protected]


Molecular Systems Biology | 2008

InnateDB: facilitating systems‐level analyses of the mammalian innate immune response

David J. Lynn; Geoffrey L. Winsor; Calvin Chan; Nicolas Richard; Matthew R. Laird; Aaron Barsky; Jennifer L. Gardy; Fiona M. Roche; Timothy H.W. Chan; Naisha Shah; Raymond Lo; Misbah Naseer; Jaimmie Que; Melissa Yau; Michael Acab; Dan Tulpan; Matthew D. Whiteside; Avinash Chikatamarla; Bernadette Mah; Tamara Munzner; Karsten Hokamp; Robert E. W. Hancock; Fiona S. L. Brinkman

Although considerable progress has been made in dissecting the signaling pathways involved in the innate immune response, it is now apparent that this response can no longer be productively thought of in terms of simple linear pathways. InnateDB (www.innatedb.ca) has been developed to facilitate systems‐level analyses that will provide better insight into the complex networks of pathways and interactions that govern the innate immune response. InnateDB is a publicly available, manually curated, integrative biology database of the human and mouse molecules, experimentally verified interactions and pathways involved in innate immunity, along with centralized annotation on the broader human and mouse interactomes. To date, more than 3500 innate immunity‐relevant interactions have been contextually annotated through the review of 1000 plus publications. Integrated into InnateDB are novel bioinformatics resources, including network visualization software, pathway analysis, orthologous interaction network construction and the ability to overlay user‐supplied gene expression data in an intuitively displayed molecular interaction network and pathway context, which will enable biologists without a computational background to explore their data in a more systems‐oriented manner.


Nucleic Acids Research | 2013

InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation

Karin Breuer; Amir K. Foroushani; Matthew R. Laird; Carol Chen; Anastasia Sribnaia; Raymond Lo; Geoffrey L. Winsor; Robert E. W. Hancock; Fiona S. L. Brinkman; David J. Lynn

InnateDB (http://www.innatedb.com) is an integrated analysis platform that has been specifically designed to facilitate systems-level analyses of mammalian innate immunity networks, pathways and genes. In this article, we provide details of recent updates and improvements to the database. InnateDB now contains >196 000 human, mouse and bovine experimentally validated molecular interactions and 3000 pathway annotations of relevance to all mammalian cellular systems (i.e. not just immune relevant pathways and interactions). In addition, the InnateDB team has, to date, manually curated in excess of 18 000 molecular interactions of relevance to innate immunity, providing unprecedented insight into innate immunity networks, pathways and their component molecules. More recently, InnateDB has also initiated the curation of allergy- and asthma-related interactions. Furthermore, we report a range of improvements to our integrated bioinformatics solutions including web service access to InnateDB interaction data using Proteomics Standards Initiative Common Query Interface, enhanced Gene Ontology analysis for innate immunity, and the availability of new network visualizations tools. Finally, the recent integration of bovine data makes InnateDB the first integrated network analysis platform for this agriculturally important model organism.

Collaboration


Dive into the Fiona S. L. Brinkman's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jennifer L. Gardy

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Raymond Lo

Simon Fraser University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge